This Core unit will be responsible for the total administrative organization and the management of the Program Project. The Core will be directed by Walter J Koch, PhD, the overall PI of this Program Project as he has carried out this role through the first funding cycle of this award. He will be assisted in the adminsitration of Core A by Ms. Nora Baglivo who will share responsiblities as the PPG Administrative Assistant. In addition, as in the PPG through the first funding cycle, a PPG Administrator will also assist Dr. Koch in the overall admistration of this program. As in the first funding period, this will be Ms. Joanne Cortese. Together with Dr. Koch, they will be responsible for the organization of the Grant including financial budgeting. This is a strength of Ms. Cortese. The primary functions of this core will be the overall scientific coordination of the research goals of this PPG and assure compliance with all NIH, NHLBI and Temple University policies. Organization with include planning of monthly data meetings of all members of the PPG group and associated scientists and meetings of the internal (twice a year) and external advisory (once a year) committees and all travel associated with this PPG. Ms. Baglivo will also support with manuscript organization for studies from this PPG and also annual progress reports. Finally, Dr. Koch will also coordinate any biostatistical assistance and consulting needed with the Biostatistics Department of Temple University as there will be needed support for analysis of data generated in the various Projects. All Projects will utilize this Core evenly.
This Core is responsible for the organization of all administrative and management needs of this Program Project and to ensure success of the primary goals to elucidate novel mechanisms involved in cardiac injury and repair. Success of the Program Project will uncover novel therapeutics effect to combat heart disease.
|Ahmad, Firdos; Lal, Hind; Zhou, Jibin et al. (2014) Cardiomyocyte-specific deletion of Gsk3? mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure. J Am Coll Cardiol 64:696-706|
|Bathgate-Siryk, Ashley; Dabul, Samalia; Pandya, Krunal et al. (2014) Negative impact of *-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms. Hypertension 63:404-12|
|Scimia, Maria Cecilia; Blass, Benjamin E; Koch, Walter J (2014) Apelin receptor: its responsiveness to stretch mechanisms and its potential for cardiovascular therapy. Expert Rev Cardiovasc Ther 12:733-41|
|Lal, Hind; Ahmad, Firdos; Parikh, Shan et al. (2014) Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease. Circ J 78:1514-9|
|Hullmann, Jonathan E; Grisanti, Laurel A; Makarewich, Catherine A et al. (2014) GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity. Circ Res 115:976-85|
|Miller, Barbara A; Hoffman, Nicholas E; Merali, Salim et al. (2014) TRPM2 channels protect against cardiac ischemia-reperfusion injury: role of mitochondria. J Biol Chem 289:7615-29|
|Tilley, Douglas G; Zhu, Weizhong; Myers, Valerie D et al. (2014) ?-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling. Circulation 130:1800-11|
|Feldman, Arthur M; Begay, Rene L; Knezevic, Tijana et al. (2014) Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathy. J Cell Physiol 229:1697-702|
|Scimia, Maria C; Gumpert, Anna M; Koch, Walter J (2014) Cardiovascular gene therapy for myocardial infarction. Expert Opin Biol Ther 14:183-95|
|Wang, JuFang; Song, Jianliang; Gao, Erhe et al. (2014) Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 306:H1066-77|
Showing the most recent 10 out of 81 publications